Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Prospective, Single-Arm, Multicenter Clinical Study of Iparomlimab and Tuvonralimab Injection in the Treatment of Patients With Previously Untreated Locally Advanced Nasopharyngeal Carcinoma

NCT07135804 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Nanchang University as lead sponsor.

NCT NCT07135804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07135804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Prospective, Single-Arm, Multicenter Clinical Study of Iparomlimab and Tuvonralimab Injection in the Treatment of Patients With Previously Untreated Locally Advanced Nasopharyngeal Carcinoma
Lead sponsor
Second Affiliated Hospital of Nanchang University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 1, 2025
Completion date
April 30, 2031
Enrollment
45 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced nasopharyngeal squamous cell carcinoma